Search Results
Jul 27, 2026, 07:15 ET TransDigm Announces Acquisition of Prince & Izant
factors that could cause actual results to differ materially from projected results can be found in TransDigm Group's most recent Annual Report on Form 10-K and other reports that TransDigm Group or its subsidiaries have filed with the Securities and Exchange Commission. Except as required by law, TransDigm
More news about: TransDigm Group Inc.
Jul 27, 2026, 07:15 ET TransDigm Announces Acquisition of Prince & Izant
factors that could cause actual results to differ materially from projected results can be found in TransDigm Group's most recent Annual Report on Form 10-K and other reports that TransDigm Group or its subsidiaries have filed with the Securities and Exchange Commission. Except as required by law, TransDigm
More news about: TransDigm Group Inc.
Jul 27, 2026, 07:10 ET Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns
cause actual results to be materially different than those expressed in forward-looking statements, please review the Company's Annual Report on Form 10-K and other reports on file with the Securities and Exchange Commission at www.sec.gov, particularly the
More news about: Healthcare Triangle, Inc.
Jul 27, 2026, 07:00 ET Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million
respect for the legal obligations that enable universities and industry to work together to advance innovation."Biohaven was represented by K&L Gates LLP and Morris James LLP. Susman Godfrey LLP and Farnan LLP represented Yale. Background of the CaseDr.
More news about: Biohaven Ltd.
Jul 27, 2026, 07:00 ET International Tower Hill Mines Announces Executive Leadership Transition to Advance Livengood Gold Project
Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026 and
More news about: International Tower Hill Mines Ltd.
Jul 27, 2026, 06:55 ET Ameren Missouri plans new energy center to deliver long-term value and around-the-clock power
materially from those anticipated. The following factors, in addition to those discussed under Risk Factors in Ameren Missouri's Annual Report on Form 10-K for the year ended December 31, 2025, and elsewhere in this release and in our other filings with the Securities and Exchange Commission, could cause
More news about: Ameren Missouri
Jul 27, 2026, 06:47 ET LG Channels Surpasses 60 Channels in the UAE Less Than a Year After Launch
In Poland, the platform offers a wide range of entertainment, including global news, sports, music and lifestyle content, while introducing dedicated K-content channels such as @K-MUSIC and NEW KFOOD through its partnership with NEW ID.LG Channels plans to continue expanding its local content offerings
More news about: LG
Jul 27, 2026, 06:45 ET Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
participated as lenders in the ABL Facility.Additional details regarding the ABL Facility will be available in the Company's Current Report on Form 8-K to be filed with the Securities and Exchange Commission.About Target HospitalityTarget Hospitality is one of North America's largest
More news about: Target Hospitality
Jul 27, 2026, 06:00 ET NHI Appoints Chris Maingot as Chief Operating Officer
not limited to, those risks and uncertainties which are described under the heading "Risk Factors" in Item 1A in the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation
More news about: National Health Investors, Inc.
Jul 27, 2026, 06:00 ET IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers
IDEAYA's filings with the Securities and Exchange Commission, including IDEAYA's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and current Reports on Form 8-K.Investor and Media ContactIDEAYA BiosciencesJoshua Bleharski, Ph.D.Chief
More news about: IDEAYA Biosciences, Inc.
Jul 27, 2026, 04:17 ET Comfytemp Expands Its Home Recovery Portfolio With Smart Cold Therapy System Designed to Make Post-Surgery Recovery More Accessible
technology, today announced the availability of its K91C1 Smart Cold Therapy System, a cold therapy solution designed to make post-operative recovery more comfortable and convenient for individuals
More news about: Comfytemp
Jul 26, 2026, 20:45 ET Synopsys Showcases Comprehensive Autonomous Engineering Workflows from Silicon to Systems, Developed with NVIDIA Technology
included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Media ContactsKelli Wheeler, [email protected]
More news about: Synopsys, Inc.
Jul 26, 2026, 13:59 ET NewAmsterdam Pharma und die Menarini Group erhalten positive Stellungnahme des CHMP mit der Empfehlung zur Erteilung einer Zulassung für Ubeslo® (Obicetrapib-Monotherapie) und Evlarco® (Festsatzkombination aus Obicetrapib und Ezetimib)
Aussagen enthaltenen abweichen, und die ausführlicher in den Abschnitten mit dem Titel „Risikofaktoren" im Jahresbericht des Unternehmens auf Formular 10-K, der am 18. Februar 2026 bei der Securities and Exchange Commission („SEC") eingereicht wurde, sowie in seinem Quartalsbericht auf Formular 10-Q, der
More news about: Menarini Industrie Farmaceutiche Riunite
Jul 25, 2026, 20:10 ET GPGI, CMPO Investors Have Opportunity to Lead GPGI, Inc. f/k/a CompoSecure, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI, CMPO) between November 3, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important September 14, 2026 lead
More news about: THE ROSEN LAW FIRM, P. A.
Jul 25, 2026, 16:21 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
on the class action.What is this about: On January 29, 2026, PennyMac filed a Current Report with the Securities Exchange Commission on Form 8-K announcing PennyMac's fourth quarter and full-year 2025 financial results. The report stated that PennyMac's "servicing segment pretax income was $37.3 million,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 25, 2026, 13:39 ET NewAmsterdam Pharma et le groupe Menarini reçoivent un avis favorable du CHMP recommandant l'autorisation de mise sur le marché d'Ubeslo® (obicetrapib en monothérapie) et d'Evlarco® (association à dose fixe d'obicetrapib et d'ézétimibe)
prospectives, qui sont décrits plus en détail dans les sections intitulées « Facteurs de risque » du rapport annuel de la Société sur le formulaire 10-K déposé auprès de la Securities and Exchange Commission (« SEC ») le 18 février 2026 et dans son rapport trimestriel sur le formulaire 10-Q déposé auprès
More news about: Menarini Industrie Farmaceutiche Riunite
Jul 25, 2026, 10:22 ET Chandigarh University's 272 Allied Health Sciences Students Secure Jobs in Prestigious Govt & Private Hospitals in Past 3 Years
SKIMS MCH Srinagar; CK Birla Hospital, Rajasthan; Government Medical College & Hospital, Chandigarh; and Government Medical College, Handwara (J&K). We also facilitated such internships for our foreign students at international institutions like Jigme Dorji Wangchuck National Referral Hospital,
More news about: Chandigarh University
Jul 25, 2026, 10:10 ET Rosen Law Firm Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
action.What is this about: On February 27, 2026, during market hours, Elauwit filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing non-reliance on "previously issued interim financial statements included in the Company's Quarterly Report on Form 10-Q for the quarter ended
More news about: THE ROSEN LAW FIRM, P. A.
Jul 24, 2026, 20:50 ET Dvaja absolventi Pekinskej univerzity získali Fieldsove medaily, 14 absolventov PKU prehovorilo na kongrese ICM 2026
tekutín, čím riešil problém, ktorý prvýkrát predostrel legendárny matematik David Hilbert pred viac ako storočím.Wangová a Deng sa prepracovali k matematike rôznymi spôsobmi, ale ich cesty sa začali v rovnakom ročníku na PKU. Ich úspechy poukazujú na rastúcu medzinárodnú prítomnosť matematikov z
More news about: Peking University
Jul 24, 2026, 20:33 ET Spoločnosť Shanghai Electric na veľtrhu WAIC 2026 predstavuje riešenia pre inteligentné továrne na báze AI
Podporujú plánovanie výrobnej linky, kontrolu kvality a prediktívnu údržbu, čím poháňajú vývoj výrobných systémov od operácií riadených skúsenosťami k operáciám riadeným dátami.Spoločnosť Shanghai Electric tiež vydala „Bielu knihu o technológii inteligentnej továrne s umelou inteligenciou", v
More news about: Shanghai Electric
Jul 24, 2026, 20:05 ET Portland General Electric declares dividend
factors identified from time-to-time in our filings with the United States Securities and Exchange Commission (SEC), including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent quarterly reports on Form 10-Q. These reports are available through the EDGAR system free-of-charge
More news about: Portland General Company
Jul 24, 2026, 18:37 ET Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
to drive adoption at launch.VectorMist: On Track for FDA 510(k) SubmissionVectorMist, Vector's perioperative pain management technology for laparoscopic surgery, remains on track for submission to the FDA for 510(k) clearance, a process that typically involves a 90-day review from
More news about: Vector Sciences & Therapeutics
Jul 24, 2026, 17:06 ET ADTRAN Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ADTRAN Holdings (ADTN)
ADTRAN investors saw shares fall after a Form 8-K reported preliminary Q2 2026 results below guidance and tied the shortfall to a delayed single-customer project. The investigation focuses on whether ADTRAN adequately disclosed risks relating to customer project timing and impact on revenue and
More news about: Levi & Korsinsky, LLP
Jul 24, 2026, 16:05 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
other factors and the general risks associated with the respective businesses of Paramount and WBD can be found in Paramount's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning
More news about: Paramount Skydance Corporation
Jul 24, 2026, 16:00 ET METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR SECOND QUARTER 2026
in the sections titled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" in the Company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q on file with the U.S. Securities and Exchange Commission (the "SEC"), and in other documents that we file with the
More news about: MetroCity Bankshares, Inc.